Seoul, South Korea

Sam Sik Kang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Sam Sik Kang and His Contribution to Cognitive Function Disorders

Introduction: Sam Sik Kang is an accomplished inventor based in Seoul, South Korea, recognized for his significant contributions to the field of pharmaceuticals. With a clear focus on enhancing cognitive health, Kang's work has a meaningful impact on the prevention and treatment of cognitive function disorders.

Latest Patents: Kang holds a notable patent for a pharmaceutical composition for the prevention or treatment of cognitive function disorders, which includes spinosin. This composition has been shown to effectively improve memory and learning ability while addressing conditions such as dementia and amnesia. His innovative approach showcases the potential of herbal extracts in the realm of cognitive enhancement.

Career Highlights: Throughout his career, Sam Sik Kang has been associated with prestigious organizations such as the Ministry of Food and Drug Safety and Dae Hwa Pharma Co., Ltd. These experiences have undoubtedly contributed to his expertise and drive to innovate in the pharmaceutical industry.

Collaborations: Kang has worked alongside talented individuals in his field, including esteemed colleagues Jong Hoon Ryu and Hyung Eun Lee. Their collaborations exemplify the synergy that exists in the world of innovation and the importance of teamwork in advancing scientific research.

Conclusion: Sam Sik Kang is a remarkable inventor whose work in cognitive function disorders is paving the way for new therapeutic avenues. His dedication to improving mental health through innovative solutions marks him as an important figure in the pharmaceutical landscape, and his contributions will continue to resonate in future research and product development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…